Alcon Laboratories (U.K) Limited

Pentagon Park, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 7UD
Telephone: +44 (0)1442 341 234
Fax: +44 (0)1442 341 200
Summary of Product Characteristics last updated on the eMC: 19/03/2007
SPC TRAVATAN

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/03/2007 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   03/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

 Section 4.8 Update of terminology
Updated on 29/11/2006 and displayed until 19/03/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 27/09/2006 and displayed until 29/11/2006
Reasons for adding or updating:
  • Removal of Black Triangle
Date of revision of text on the SPC:   11/2001
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Black Triangle has been removed as it no longer applies
Updated on 05/09/2003 and displayed until 27/09/2006
Reasons for adding or updating:
  • Addition of Black Triangle
Updated on 05/09/2003 and displayed until 05/09/2003
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
Updated on 17/01/2003 and displayed until 05/09/2003
Reasons for adding or updating:
  • New SPC for new product
Updated on 06/12/2001 and displayed until 17/01/2003
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   travoprost


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk